Source: Cancer Consultants
Date: December 24, 2009
Summary:
Researchers from Canada have reported that autologous stem cell transplantation (SCT) followed by a sibling reduced-intensity allogeneic SCT results in progression-free (PFS) and overall survival (OS) of 96% at three and five years in patients with relapsed follicular lymphoma (FL). The details of this study were presented at the 2009 meeting of the American Society of Hematology (ASH) in New Orleans in the first week of December.[1]
